FORM OF CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • June 29th, 2023 • Sigilon Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 29th, 2023 Company Industry JurisdictionThis CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●], 2023 (this “Agreement”), is entered into by and among Eli Lilly and Company, an Indiana corporation (“Parent”), Shenandoah Acquisition Corporation, a Delaware corporation and wholly owned Subsidiary of Parent (“Purchaser”), and [●], a [●], as Rights Agent (as defined herein). Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Merger Agreement (as defined herein).
FORM OF CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • October 18th, 2022 • Akouos, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 18th, 2022 Company Industry JurisdictionThis CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●] (this “Agreement”), is entered into by and among Eli Lilly and Company, an Indiana corporation (“Parent”), Kearny Acquisition Corp., a Delaware corporation and wholly owned Subsidiary of Parent (“Purchaser”), and [●], a [●], as Rights Agent (as defined herein). Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Merger Agreement (as defined herein).